Management of Duodenal Atresia in the setting of Congenital Leukemia with Massive Hepatomegaly

Down's syndrome (DS) is associated with duodenal atresia (DA) in about 8-10% of cases. Transient Myeloproliferative Disorder (TMD)/Acute Myeloid Leukemia (AML) is also associated with the trisomy 21 mutation. The occurrence of the two conditions together complicates the diagnosis and surgical m...

Full description

Bibliographic Details
Main Author: Sathyaprasad C Burjonrappa
Format: Article
Language:English
Published: EL-Med-Pub 2013-04-01
Series:Journal of Neonatal Surgery
Subjects:
Online Access:https://www.jneonatalsurg.com/ojs/index.php/jns/article/view/44
_version_ 1811258319084453888
author Sathyaprasad C Burjonrappa
author_facet Sathyaprasad C Burjonrappa
author_sort Sathyaprasad C Burjonrappa
collection DOAJ
description Down's syndrome (DS) is associated with duodenal atresia (DA) in about 8-10% of cases. Transient Myeloproliferative Disorder (TMD)/Acute Myeloid Leukemia (AML) is also associated with the trisomy 21 mutation. The occurrence of the two conditions together complicates the diagnosis and surgical management of the DA. We discuss the technical aspects of management of the DA in this clinical setting.
first_indexed 2024-04-12T18:11:29Z
format Article
id doaj.art-cb6c7df3dc7742c0863a02d667321146
institution Directory Open Access Journal
issn 2226-0439
language English
last_indexed 2024-04-12T18:11:29Z
publishDate 2013-04-01
publisher EL-Med-Pub
record_format Article
series Journal of Neonatal Surgery
spelling doaj.art-cb6c7df3dc7742c0863a02d6673211462022-12-22T03:21:48ZengEL-Med-PubJournal of Neonatal Surgery2226-04392013-04-012310.47338/jns.v2.44Management of Duodenal Atresia in the setting of Congenital Leukemia with Massive HepatomegalySathyaprasad C Burjonrappa0University of BuffaloDown's syndrome (DS) is associated with duodenal atresia (DA) in about 8-10% of cases. Transient Myeloproliferative Disorder (TMD)/Acute Myeloid Leukemia (AML) is also associated with the trisomy 21 mutation. The occurrence of the two conditions together complicates the diagnosis and surgical management of the DA. We discuss the technical aspects of management of the DA in this clinical setting.https://www.jneonatalsurg.com/ojs/index.php/jns/article/view/44Down's syndromeDuodenal atresiaTransient myeloproliferative disorder
spellingShingle Sathyaprasad C Burjonrappa
Management of Duodenal Atresia in the setting of Congenital Leukemia with Massive Hepatomegaly
Journal of Neonatal Surgery
Down's syndrome
Duodenal atresia
Transient myeloproliferative disorder
title Management of Duodenal Atresia in the setting of Congenital Leukemia with Massive Hepatomegaly
title_full Management of Duodenal Atresia in the setting of Congenital Leukemia with Massive Hepatomegaly
title_fullStr Management of Duodenal Atresia in the setting of Congenital Leukemia with Massive Hepatomegaly
title_full_unstemmed Management of Duodenal Atresia in the setting of Congenital Leukemia with Massive Hepatomegaly
title_short Management of Duodenal Atresia in the setting of Congenital Leukemia with Massive Hepatomegaly
title_sort management of duodenal atresia in the setting of congenital leukemia with massive hepatomegaly
topic Down's syndrome
Duodenal atresia
Transient myeloproliferative disorder
url https://www.jneonatalsurg.com/ojs/index.php/jns/article/view/44
work_keys_str_mv AT sathyaprasadcburjonrappa managementofduodenalatresiainthesettingofcongenitalleukemiawithmassivehepatomegaly